SFX by Ex Libris Inc.

Title:	Gene therapy death prompts review of adenovirus vector
Source:	Science [0036-8075] Marshall, E yr:2000

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Yarborough, M.. "Public trust and research a decade later: What have we learned since Jesse Gelsinger's death?" Molecular genetics and metabolism 97.1 (2009): 4-5.
description	2.	Boyce, N. "Trial halted after gene shows up in semen." Nature 414.6865 (2001): 677-677.
description	3.	Raper, S. "Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer." Molecular genetics and metabolism 80.1-2 (2003): 148-158.
description	4.	Mukherjee, S. "Endocytosis." Physiological reviews 77.3 (1997): 759-803.
description	5.	Marshall, E. "Gene therapy on trial." Science 288.5468 (2000): 951-957.
description	6.	Wilson, James M M. "Lessons learned from the gene therapy trial for ornithine transcarbamylase deficiency." Molecular genetics and metabolism 96.4 (2009): 151-7.
description	7.	Byers, Lynn F. "Gene therapy in the post-Gelsinger era." JONA'S healthcare law, ethics, and regulation 4.4: 104-110.
description	8.	Conner, Sean D D. "Regulated portals of entry into the cell." Nature 422.6927 (2003): 37-44.
description	9.	Stolberg, Sheryl Gay G. "The biotech death of Jesse Gelsinger." N Y Times Mag 28.51720 (1999): 136-140.
description	10.	Leboulch, P. "Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia." Nature 467.7313 (2010): 318-322.
description	11.	Zivotofsky, Ari Z. "A Jewish Response to the Vatican's New Bioethical Guidelines." American journal of bioethics 9.11 (2009): 26-30.
description	12.	Shrebnivas, S. "Who killed Jesse Gelsinger? Ethical issues in human gene therapy." Monash bioethics review 19.3 (2000): 35-43.
description	13.	Puttagunta PS, P Saradhi S. "Conflict of interest in clinical research: direct payment to the investigators for finding human subjects and health information." Health law review 10.2 (2002): 30-2.
description	14.	Goldstein, J L L. "Coated pits, coated vesicles, and receptor-mediated endocytosis." Nature 279.5715 (1979): 679-85.
description	15.	Resnik, David B B. "Disclosing conflicts of interest to research subjects: an ethical and legal analysis." Accountability in research 11.2 (2004): 141-59.
description	16.	GRUENBERG, J. "MEMBRANE-TRANSPORT IN THE ENDOCYTIC PATHWAY." Current opinion in cell biology 7.4 (1995): 552-563.
description	17.	Moore, Adam D. D. "Owning genetic information and gene enhancement techniques: Why privacy and property rights may undermine social control of the human genome." Bioethics 14.2 (2000): 97-119.
description	18.	Stokstad, E. "Toxicity testing: the many arts of persuasion." Science 286.5442 (1999): 1070-1070.
description	19.	Theodore, F. "Principles for Human Gene Therapy Studies." Science 287.5461 (2000): 2163-2165.
description	20.	HE, B C. "A SIMPLIFIED SYSTEM FOR GENERATING RECOMBINANT ADENOVIRUSES." Proceedings of the National Academy of Sciences of the United States of America 95.5 (1998): 2509-14.